26860 Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial

Autor:	Külli Kingo, Prayashi Ghelani, Vivian Laquer, Deborah L. Keefe, John Browning, Pascal Forrer, Nina Magnolo, Rafal Mazur, Manmath Patekar, Adam Reich, Jacek C Szepietowski
Rok vydání:	2021
Předmět:	Moderate to severe Plaque psoriasis medicine.medical_specialty Randomized controlled trial business.industry law Internal medicine Medicine Secukinumab Dermatology business law.invention
Zdroj:	Journal of the American Academy of Dermatology. 85:AB119
ISSN:	0190-9622
DOI:	10.1016/j.jaad.2021.06.493
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::430e39eabdde73cbe5024c9b2948ab7b https://doi.org/10.1016/j.jaad.2021.06.493 Zobrazit plný text záznamu Full Text from ScienceDirect